This inventor holds 5 USPTO granted patents. Top assignees: Licentia, Ltd., Other. Active years: 1998-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- 113 43 Stockholm, SE (1998 - 1999)
- Stockholm, SE (1998 - 2004)
Company Filing History:
1 out of 20 
4 out of 834,570 Years Active: 1998-2004
Title: Innovations and Contributions of Carlos F Ibanez
Introduction
Carlos F Ibanez is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of neurobiology, particularly through his innovative patents. With a total of 5 patents, his work has advanced the understanding of neurotrophic factors and their receptors.
Latest Patents
Ibanez's latest patents include groundbreaking inventions related to glial cell line-derived neurotrophic factor (GDNF) receptors. His patent on "Assays using glial cell line-derived neurotrophic factor receptors" discloses the cellular expression, isolation, biochemical characterization, and sequences of GDNF receptors. Notably, c-RET is identified as one receptor for GDNF, along with additional novel receptors. Furthermore, he has developed monoclonal antibodies directed against GDNF.
Another significant patent involves a novel serine threonine kinase receptor known as ALK-7. This invention encompasses nucleic acid molecules coding for ALK-7, ALK-7 polypeptides, and recombinant nucleic acid molecules. It also includes methods for detecting ALK-7 nucleic acid or polypeptide in samples, as well as diagnostic and therapeutic uses for ALK-7. The invention further explores ligands, agonists, and antagonists of the ALK-7 receptor.
Career Highlights
Throughout his career, Carlos F Ibanez has worked with various companies, including Licentia, Ltd. His innovative research has positioned him as a key figure in the field of neurodegenerative diseases. His contributions have not only advanced scientific knowledge but have also paved the way for potential therapeutic applications.
Collaborations
Ibanez has collaborated with notable colleagues such as Mikael Ryden and Henrik Jornvall. These partnerships have enhanced his research and contributed to the success of his inventions.
Conclusion
Carlos F Ibanez's work exemplifies the impact of innovation in the field of neurobiology. His patents and collaborations reflect a commitment to advancing scientific understanding and developing therapeutic solutions. His contributions continue to influence the landscape of neurotrophic factor research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile